Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Ayahuasca in adolescence: Qaualitative results.

de Rios MD, Grob CS, Lopez E, da Silviera DX, Alonso LK, Doering-Silveira E.

J Psychoactive Drugs. 2005 Jun;37(2):135-9.

PMID:
16149325
2.

Report on psychoactive drug use among adolescents using ayahuasca within a religious context.

Doering-Silveira E, Grob CS, de Rios MD, Lopez E, Alonso LK, Tacla C, Da Silveira DX.

J Psychoactive Drugs. 2005 Jun;37(2):141-4.

PMID:
16149326
3.

Ayahuasca and the process of regulation in Brazil and internationally: implications and challenges.

Labate BC, Feeney K.

Int J Drug Policy. 2012 Mar;23(2):154-61. doi: 10.1016/j.drugpo.2011.06.006.

PMID:
21856141
4.
5.
6.

Ayahuasca in adolescence: a neuropsychological assessment.

Doering-Silveira E, Lopez E, Grob CS, de Rios MD, Alonso LK, Tacla C, Shirakawa I, Bertolucci PH, Da Silveira DX.

J Psychoactive Drugs. 2005 Jun;37(2):123-8.

PMID:
16149323
7.

Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.

Santos RG, Landeira-Fernandez J, Strassman RJ, Motta V, Cruz AP.

J Ethnopharmacol. 2007 Jul 25;112(3):507-13. Epub 2007 Apr 25.

PMID:
17532158
8.

Ayahuasca use in cross-cultural perspective.

de Rios MD, Grob CS.

J Psychoactive Drugs. 2005 Jun;37(2):119-21. No abstract available.

PMID:
16149322
9.

Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology.

dos Santos RG.

J Psychoactive Drugs. 2013 Jan-Mar;45(1):68-78. Review.

PMID:
23662333
10.

The globalization of ayahuasca: harm reduction or benefit maximization?

Tupper KW.

Int J Drug Policy. 2008 Aug;19(4):297-303. doi: 10.1016/j.drugpo.2006.11.001. Epub 2006 Dec 4.

PMID:
18638702
11.

Ayahuasca and human destiny.

McKenna DJ.

J Psychoactive Drugs. 2005 Jun;37(2):231-4. Review.

PMID:
16149337
12.

Ayahuasca in adolescence: a preliminary psychiatric assessment.

Da Silveira DX, Grob CS, de Rios MD, Lopez E, Alonso LK, Tacla C, Doering-Silveira E.

J Psychoactive Drugs. 2005 Jun;37(2):129-33.

PMID:
16149324
13.

Analytical techniques for the determination of tryptamines and β-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices.

Gaujac A, Navickiene S, Collins MI, Brandt SD, de Andrade JB.

Drug Test Anal. 2012 Jul-Aug;4(7-8):636-48. doi: 10.1002/dta.1343. Epub 2012 May 11. Review.

PMID:
22577086
14.

Health status of ayahuasca users.

Barbosa PC, Mizumoto S, Bogenschutz MP, Strassman RJ.

Drug Test Anal. 2012 Jul-Aug;4(7-8):601-9. doi: 10.1002/dta.1383. Epub 2012 Jul 4. Review.

PMID:
22761152
16.

Consumption of ayahuasca by children and pregnant women: medical controversies and religious perspectives.

Labate BC.

J Psychoactive Drugs. 2011 Jan-Mar;43(1):27-35. doi: 10.1080/02791072.2011.566498.

PMID:
21615005
17.

Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament.

Halpern JH, Sherwood AR, Passie T, Blackwell KC, Ruttenber AJ.

Med Sci Monit. 2008 Aug;14(8):SR15-22.

PMID:
18668010
18.

Hallucinogens and redemption.

de Rios MD, Grob CS, Baker JR.

J Psychoactive Drugs. 2002 Jul-Sep;34(3):239-48.

PMID:
12422934
19.

A study of ayahuasca use in North America.

Harris R, Gurel L.

J Psychoactive Drugs. 2012 Jul-Aug;44(3):209-15.

PMID:
23061320
20.

The effects of ayahuasca ritual participation on gay and lesbian identity.

Cavnar C.

J Psychoactive Drugs. 2014 Jul-Aug;46(3):252-60. doi: 10.1080/02791072.2014.920117.

PMID:
25052884

Supplemental Content

Support Center